GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Genertec Universal Medical Group Co Ltd (HKSE:02666) » Definitions » Piotroski F-Score

Genertec Universal Medical Group Co (HKSE:02666) Piotroski F-Score : 6 (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genertec Universal Medical Group Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Genertec Universal Medical Group Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Genertec Universal Medical Group Co's Piotroski F-Score or its related term are showing as below:

HKSE:02666' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 6
Current: 6

During the past 10 years, the highest Piotroski F-Score of Genertec Universal Medical Group Co was 6. The lowest was 3. And the median was 4.


Genertec Universal Medical Group Co Piotroski F-Score Historical Data

The historical data trend for Genertec Universal Medical Group Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genertec Universal Medical Group Co Piotroski F-Score Chart

Genertec Universal Medical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 5.00 4.00 6.00

Genertec Universal Medical Group Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 - 4.00 - 6.00

Competitive Comparison of Genertec Universal Medical Group Co's Piotroski F-Score

For the Credit Services subindustry, Genertec Universal Medical Group Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genertec Universal Medical Group Co's Piotroski F-Score Distribution in the Credit Services Industry

For the Credit Services industry and Financial Services sector, Genertec Universal Medical Group Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Genertec Universal Medical Group Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was HK$2,308 Mil.
Cash Flow from Operations was HK$5,462 Mil.
Revenue was HK$14,930 Mil.
Gross Profit was HK$5,001 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (85965.065 + 87879.385) / 2 = HK$86922.225 Mil.
Total Assets at the begining of this year (Dec22) was HK$85,965 Mil.
Long-Term Debt & Capital Lease Obligation was HK$31,289 Mil.
Total Current Assets was HK$33,574 Mil.
Total Current Liabilities was HK$32,894 Mil.
Net Income was HK$2,189 Mil.

Revenue was HK$13,482 Mil.
Gross Profit was HK$5,019 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (85590.025 + 85965.065) / 2 = HK$85777.545 Mil.
Total Assets at the begining of last year (Dec21) was HK$85,590 Mil.
Long-Term Debt & Capital Lease Obligation was HK$32,895 Mil.
Total Current Assets was HK$31,447 Mil.
Total Current Liabilities was HK$29,551 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Genertec Universal Medical Group Co's current Net Income (TTM) was 2,308. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Genertec Universal Medical Group Co's current Cash Flow from Operations (TTM) was 5,462. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=2308.242/85965.065
=0.02685093

ROA (Last Year)=Net Income/Total Assets (Dec21)
=2188.56/85590.025
=0.02557027

Genertec Universal Medical Group Co's return on assets of this year was 0.02685093. Genertec Universal Medical Group Co's return on assets of last year was 0.02557027. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Genertec Universal Medical Group Co's current Net Income (TTM) was 2,308. Genertec Universal Medical Group Co's current Cash Flow from Operations (TTM) was 5,462. ==> 5,462 > 2,308 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=31289.158/86922.225
=0.35996729

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=32894.818/85777.545
=0.38348985

Genertec Universal Medical Group Co's gearing of this year was 0.35996729. Genertec Universal Medical Group Co's gearing of last year was 0.38348985. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=33573.735/32893.695
=1.02067387

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=31447.374/29550.88
=1.06417724

Genertec Universal Medical Group Co's current ratio of this year was 1.02067387. Genertec Universal Medical Group Co's current ratio of last year was 1.06417724. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Genertec Universal Medical Group Co's number of shares in issue this year was 2082.889. Genertec Universal Medical Group Co's number of shares in issue last year was 2077.1. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5000.603/14930.304
=0.33492975

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5018.844/13482.289
=0.37225459

Genertec Universal Medical Group Co's gross margin of this year was 0.33492975. Genertec Universal Medical Group Co's gross margin of last year was 0.37225459. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=14930.304/85965.065
=0.17367874

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=13482.289/85590.025
=0.15752173

Genertec Universal Medical Group Co's asset turnover of this year was 0.17367874. Genertec Universal Medical Group Co's asset turnover of last year was 0.15752173. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Genertec Universal Medical Group Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Genertec Universal Medical Group Co  (HKSE:02666) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Genertec Universal Medical Group Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Genertec Universal Medical Group Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Genertec Universal Medical Group Co (HKSE:02666) Business Description

Traded in Other Exchanges
Address
8-1 Chongwenmenwai Street, 4th, 5th and 13th Floor, West Wing of Hademen Plaza, Dongcheng District, Beijing, CHN
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and The hospital group business comprises medical services, hospital, and healthcare management, import and export trade, and domestic trade of medical-related goods and life cycle management of equipment assets. Geographically, it derives a majority of its revenue from Mainland China.
Executives
Citic Capital Holdings Limited 2201 Interest of corporation controlled by you
Tong Yong Ji Shu Ji Tuan Xiang Gang Guo Ji Zi Ben You Xian Gong Si 2101 Beneficial owner
Zhong Guo Tong Yong Ji Shu Ji Tuan Kong Gu You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Cp Management Holdings Limited 2201 Interest of corporation controlled by you
Trustar Capital Holdings Limited 2201 Interest of corporation controlled by you
Sounda Properties Limited 2201 Interest of corporation controlled by you
Chu Mang Yee 2201 Interest of corporation controlled by you
Meta Group Limited 2201 Interest of corporation controlled by you
Sounda Hopson Technology Holdings Limited 2201 Interest of corporation controlled by you
Sounda Hopson Technology Investment Limited 2201 Interest of corporation controlled by you
Zhang Yichen 2201 Interest of corporation controlled by you
Citic Capital Partners Limited 2201 Interest of corporation controlled by you

Genertec Universal Medical Group Co (HKSE:02666) Headlines

No Headlines